Yvonne Greenstreet is the CEO of Alnylam Pharmaceuticals, a biopharmaceutical company specializing in RNA therapeutics. Based in Cambridge, Massachusetts.
Yvonne Greenstreet is the CEO of Alnylam Pharmaceuticals, a biopharmaceutical company specializing in RNA therapeutics. She was recognized as the 2024 Woman of the Year by the Boston Business Journal for her leadership at Alnylam. Before this, she held senior leadership roles at Microsoft and AstraZeneca, overseeing global commercial strategies.
Full founder directory · Investor directory · Company funding database · Fundraising library